Merck & Co's Gardasil adds US indication for boys and men
19 October 2009
Sue Sutter
Merck & Co's human papillomavirus vaccine Gardasil has extended its US label to include use in boys and men. On October 16th, the
FDA approved a new indication in males aged nine to 26 years to prevent genital warts caused by HPV types 6 and 11.
The sBLA approval came the same...
Please Login to read the full article.